📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: LAT Pharma

1.1 - Company Overview

LAT Pharma Logo

LAT Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery, development, and commercialization of novel drug therapies for people with advanced liver cirrhosis and its life-threatening complications, initially targeting ascites.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to LAT Pharma

Quirem Logo

Quirem

HQ: The Netherlands Website
  • Description: Provider of next-generation holmium-166-based radioactive microspheres for Selective Internal Radiation Therapy (SIRT), a radioembolization treatment for liver tumors, developing and commercializing SIRT microspheres and medical devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quirem company profile →
Envizion Medical Logo

Envizion Medical

HQ: Israel Website
  • Description: Provider of electromagnetic feeding tube placement devices, including the ENvue System, which uses navigation, integrated sensors, and body mapping to ensure safe, rapid placement, and the ENvue Enteral Feeding Tube with built-in sensors that activate in electromagnetic fields for accurate placement and post-procedure position checks without re-insertion.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Envizion Medical company profile →
Neurogastrx Logo

Neurogastrx

HQ: United States Website
  • Description: Provider of biopharmaceutical drug development, focusing on NG101, an oral small molecule dopamine D2 receptor antagonist for the treatment of gastroparesis, which has completed a Phase 2 clinical trial.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neurogastrx company profile →
Napo Pharmaceuticals Logo

Napo Pharmaceuticals

HQ: United States Website
  • Description: Provider of proprietary pharmaceuticals for gastrointestinal indications and insulin-resistant diseases, offering Mytesi (crofelemer) for chronic diarrhea in HIV/AIDS on antiretroviral therapy; NP-300, a drug candidate for moderate to severe infectious diarrhea including cholera; NP-500 for insulin-resistant diseases; CRO-IBS for diarrhea-predominant IBS; and an Investigator-Initiated Trials program on crofelemer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Napo Pharmaceuticals company profile →
Ironwood Pharmaceuticals Logo

Ironwood Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceuticals for gastrointestinal and cardiovascular diseases, including LINZESS (linaclotide) for IBS-C and CIC; and a pipeline of investigational therapies: apraglutide for SBS-IF; CNP-104 for primary biliary cholangitis; and IW-3300, a GC-C agonist for visceral pain conditions such as interstitial cystitis/bladder pain syndrome and endometriosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ironwood Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for LAT Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to LAT Pharma

2.2 - Growth funds investing in similar companies to LAT Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for LAT Pharma

4.2 - Public trading comparable groups for LAT Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to LAT Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About LAT Pharma

What does LAT Pharma do?

LAT Pharma is a provider of discovery, development, and commercialization of novel drug therapies for people with advanced liver cirrhosis and its life-threatening complications, initially targeting ascites.

Who are LAT Pharma's competitors?

LAT Pharma's competitors and similar companies include Quirem, Envizion Medical, Neurogastrx, Napo Pharmaceuticals, and Ironwood Pharmaceuticals.

Where is LAT Pharma headquartered?

LAT Pharma is headquartered in United States.

How many employees does LAT Pharma have?

LAT Pharma has 1,000 employees 🔒.

When was LAT Pharma founded?

LAT Pharma was founded in 2010 🔒.

What sector and industry vertical is LAT Pharma in?

LAT Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for LAT Pharma

Who are the top strategic acquirers in LAT Pharma's sector and industry

Top strategic M&A buyers and acquirers in LAT Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for LAT Pharma?

Top strategic M&A buyers groups and sectors for LAT Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in LAT Pharma's sector and industry vertical

Which are the top PE firms investing in LAT Pharma's sector and industry vertical?

Top PE firms investing in LAT Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in LAT Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in LAT Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in LAT Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to LAT Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in LAT Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for LAT Pharma?

The key public trading comparables and valuation benchmarks for LAT Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for LAT Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for LAT Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in LAT Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for LAT Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in LAT Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in LAT Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for LAT Pharma